Bright Financial Statements From 2010 to 2024

DRUG Stock  USD 44.00  4.82  12.30%   
Bright Minds financial statements provide useful quarterly and yearly information to potential Bright Minds Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bright Minds financial statements helps investors assess Bright Minds' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bright Minds' valuation are summarized below:
Market Capitalization
268.3 M
Earnings Share
(0.63)
There are over one hundred available fundamental signals for Bright Minds Biosciences, which can be analyzed over time and compared to other ratios. Active traders should verify all of Bright Minds Biosciences prevailing fundamental drivers against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. The current Market Cap is estimated to decrease to about 22.9 M. Enterprise Value is estimated to decrease to about 10.4 M
Check Bright Minds financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bright Minds' main balance sheet or income statement drivers, such as Depreciation And Amortization of 51.8 K, Interest Expense of 21.6 K or Selling General Administrative of 1.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.32. Bright financial statements analysis is a perfect complement when working with Bright Minds Valuation or Volatility modules.
  
Check out the analysis of Bright Minds Correlation against competitors.

Bright Minds Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets8.8 M7.9 M3.9 M
Slightly volatile
Other Current Liabilities27.3 K28.8 K41.6 K
Pretty Stable
Total Current Liabilities567.5 K323 K250.9 K
Slightly volatile
Total Stockholder Equity8.2 M7.6 M3.6 M
Slightly volatile
Net Tangible Assets8.4 M12.1 M4.1 M
Slightly volatile
Accounts Payable199.2 K209.7 K193.5 K
Slightly volatile
Cash8.6 M7.8 M3.7 M
Slightly volatile
Non Current Assets Total64.5 K76.4 K73.7 K
Pretty Stable
Cash And Short Term Investments8.6 M7.8 M3.7 M
Slightly volatile
Common Stock Shares Outstanding2.3 M4.3 M1.8 M
Slightly volatile
Liabilities And Stockholders Equity8.8 M7.9 M3.9 M
Slightly volatile
Total Liabilities583.3 K323 K256.8 K
Slightly volatile
Total Current Assets8.7 M7.8 M3.8 M
Slightly volatile
Intangible Assets1.711.81.2 K
Slightly volatile
Common Stock20.8 M39 M10.4 M
Slightly volatile
Good Will1.6 K1.8 KK
Slightly volatile
Other Current Assets95.1 K58.2 K88.9 K
Pretty Stable
Net Invested Capital10.2 M7.6 M4.1 M
Slightly volatile
Capital Stock25.9 M39 M11.2 M
Slightly volatile
Net Working Capital10.2 M7.5 M4.1 M
Slightly volatile
Net Receivables31.6 K33.3 K98 K
Slightly volatile
Short Term Investments69 K77.6 K84.5 K
Slightly volatile
Short and Long Term Debt Total85.4 K66.2 K126.9 K
Slightly volatile
Short Term Debt77.8 K84.6 K70.1 K
Slightly volatile
Property Plant Equipment111.1 K125 K136.1 K
Slightly volatile

Bright Minds Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization51.8 K65.2 K155.3 K
Slightly volatile
Selling General Administrative1.3 M2.4 M684.5 K
Slightly volatile
Selling And Marketing Expenses130.5 K137.3 K142 K
Slightly volatile
Other Operating Expenses6.8 M8.3 M3.1 M
Slightly volatile
Research Development5.3 M5.7 M2.3 M
Slightly volatile
Total Operating Expenses6.8 M8.3 M3.1 M
Slightly volatile
Cost Of Revenue43.2 K83.3 K18.1 K
Slightly volatile

Bright Minds Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation87.5 K83.3 K21 K
Slightly volatile
Total Cash From Financing Activities2.4 M2.5 M2.7 M
Slightly volatile
End Period Cash Flow8.6 M7.8 M3.7 M
Slightly volatile
Change To Netincome548.8 K744.8 K348.5 K
Slightly volatile
Change To Liabilities924.9 K880.9 K329.6 K
Slightly volatile
Stock Based Compensation844 K1.3 M446 K
Slightly volatile
Begin Period Cash Flow8.9 M13.4 M3.7 M
Slightly volatile
Issuance Of Capital StockM1.1 MM
Pretty Stable
Change To Inventory62.3 K41.1 K93.8 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
PTB Ratio1.321.39264
Slightly volatile
Book Value Per Share2.81.61.5144
Slightly volatile
Average Payables459.6 K642.9 K302.4 K
Slightly volatile
Capex To Depreciation1.0E-41.0E-41.0E-4
Slightly volatile
PB Ratio1.321.39264
Slightly volatile
Payables Turnover0.380.360.0797
Slightly volatile
Cash Per Share2.931.651.5603
Slightly volatile
Days Payables OutstandingK1.1 K60.5 K
Slightly volatile
Income Quality0.620.860.6393
Slightly volatile
Intangibles To Total Assets1.0E-41.0E-40.0075
Slightly volatile
Net Debt To EBITDA0.670.830.7755
Pretty Stable
Current Ratio11.4821.838.1661
Slightly volatile
Tangible Book Value Per Share2.81.61.5133
Slightly volatile
Graham Number11.168.016.1249
Slightly volatile
Shareholders Equity Per Share2.81.61.5144
Slightly volatile
Capex Per Share0.00.00.0
Slightly volatile
Graham Net Net2.751.591.4555
Slightly volatile
Average Receivables106.4 K119.7 K130.3 K
Slightly volatile
Interest Debt Per Share0.00580.00610.0733
Slightly volatile
Price Book Value Ratio1.321.39264
Slightly volatile
Days Of Payables OutstandingK1.1 K60.5 K
Slightly volatile
Ebt Per Ebit1.111.151.0191
Slightly volatile
Company Equity Multiplier1.251.21.2317
Slightly volatile
Quick Ratio11.4821.838.1661
Slightly volatile
Net Income Per E B T0.80.910.9893
Slightly volatile
Cash Ratio11.2621.628.044
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.80.90.98
Slightly volatile
Price To Book Ratio1.321.39264
Slightly volatile
Price Fair Value1.321.39264
Slightly volatile

Bright Minds Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap22.9 M24.1 M47.8 M
Slightly volatile
Enterprise Value10.4 M10.9 M43.2 M
Slightly volatile

Bright Fundamental Market Drivers

Cash And Short Term Investments6.7 M

Bright Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Bright Minds Financial Statements

Bright Minds stakeholders use historical fundamental indicators, such as Bright Minds' revenue or net income, to determine how well the company is positioned to perform in the future. Although Bright Minds investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bright Minds' assets and liabilities are reflected in the revenues and expenses on Bright Minds' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bright Minds Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue83.3 K43.2 K

Currently Active Assets on Macroaxis

When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:
Check out the analysis of Bright Minds Correlation against competitors.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.63)
Return On Assets
(0.29)
Return On Equity
(0.52)
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.